Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shailen Shah

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|August 3, 2016
Zika VirusJack FitzSimmons, Shailen Shah
Allergy and Asthma Proceedings|February 20, 2010
The functionality of a budesonide/formoterol pressurized metered-dose inhaler with an integrated actuation counterShailen Shah, Martha White, Tom Uryniak, et al.
Obstetrics and Gynecology|July 12, 2018
Factors Associated With Informative Redraw After an Initial No Result in Noninvasive Prenatal TestingPeter Benn, Elizabeth Valenti, Shailen Shah, et al.
Obstetrics and Gynecology|June 8, 2002
Placenta accretaJay Goldberg, Shailen Shah, Leonardo Pereira, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 4, 2004
Patient preferences for sensory attributes of intranasal corticosteroids and willingness to adhere to prescribed therapy for allergic rhinitis: a conjoint analysisParthiv J Mahadevia, Shailen Shah, Christopher Leibman, et al.
Allergy and Asthma Proceedings|November 26, 2009
Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitisShailen Shah, William Berger, William Lumry, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 18, 2006
Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitisWilliam Berger, Frank Hampel, Jonathan Bernstein, et al.
Allergy & Rhinology (Providence, R.I.)|June 2, 2017
Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitisShailen Shah, William Berger, William Lumry, et al.
Journal of Managed Care Pharmacy : JMCP|March 7, 2006
Willingness to pay for sensory attributes of intranasal corticosteroids among patients with allergic rhinitisParthiv Mahadevia, Shailen Shah, Sally Mannix, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 11, 2014
Long-term, randomized safety study of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) in subjects with chronic rhinitisWilliam E Berger, Shailen Shah, Phil Lieberman, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|August 3, 2016
Zika VirusJack FitzSimmons, Shailen Shah
Allergy and Asthma Proceedings|February 20, 2010
The functionality of a budesonide/formoterol pressurized metered-dose inhaler with an integrated actuation counterShailen Shah, Martha White, Tom Uryniak, et al.
Obstetrics and Gynecology|July 12, 2018
Factors Associated With Informative Redraw After an Initial No Result in Noninvasive Prenatal TestingPeter Benn, Elizabeth Valenti, Shailen Shah, et al.
Obstetrics and Gynecology|June 8, 2002
Placenta accretaJay Goldberg, Shailen Shah, Leonardo Pereira, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 4, 2004
Patient preferences for sensory attributes of intranasal corticosteroids and willingness to adhere to prescribed therapy for allergic rhinitis: a conjoint analysisParthiv J Mahadevia, Shailen Shah, Christopher Leibman, et al.
Allergy and Asthma Proceedings|November 26, 2009
Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitisShailen Shah, William Berger, William Lumry, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 18, 2006
Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitisWilliam Berger, Frank Hampel, Jonathan Bernstein, et al.
Allergy & Rhinology (Providence, R.I.)|June 2, 2017
Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitisShailen Shah, William Berger, William Lumry, et al.
Journal of Managed Care Pharmacy : JMCP|March 7, 2006
Willingness to pay for sensory attributes of intranasal corticosteroids among patients with allergic rhinitisParthiv Mahadevia, Shailen Shah, Sally Mannix, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 11, 2014
Long-term, randomized safety study of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) in subjects with chronic rhinitisWilliam E Berger, Shailen Shah, Phil Lieberman, et al.
Pageof 2